Eur J Musculoskel Dis 2024 Sep-Dec;13(3):40-46
RETROSPECTIVE OBSERVATIONAL STUDY
NEEDLE-FREE INFILTRATION OF KEY MYOFASCIAL TRIGGER POINTS IN THE TREATMENT OF POSTURAL DYSFUNCTION ASSOCIATED WITH CHRONIC MYOFASCIAL PAIN SYNDROME
G. Barassi1*, M. Panunzio2, L. Prosperi1, G.L. Matera1, V. Guglielmi1, C. Marinucci1, S. Cristiani1, G. Ianieri1, P. Galasso1 and P.E. Gallenga1
1 Center for Physiotherapy, Rehabilitation and Reeducation (Ce.Fi.R.R.), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy;
2 Responsible Research Hospital, Campobasso, Italy.
*Correspondence to:
Giovanni Barassi,
Center for Physiotherapy, Rehabilitation and Reeducation (Ce.Fi.R.R.),
“G. d’Annunzio” University of Chieti-Pescara,
66013 Chieti, Italy.
e-mail: coordftgb@unich.it
| Received: 22 October, 2024 Accepted: 17 December, 2024
|
ISSN 2975-044X (online) ISSN 2038-4106 (print) Copyright © by BIOLIFE 2024 This publication and/or article is for individual use only and may not be further reproduced without written permission from the copyright holder. Unauthorized reproduction may result in financial and other penalties. Disclosure: All authors report no conflicts of interest relevant to this article. |
ABSTRACT
Myofascial Pain Syndrome (MPS) is a pathology characterized by pain and biomechanical-postural alterations in the presence of myofascial trigger points (MTrPs). Among the treatment techniques for MPS, MTrPs infiltrations with dry needling or with the injection of pharmacological substances is often used, which however, can present criticalities in terms of safety and tolerability. However, recent technological developments allow to obtain deeply focused active ingredient delivery effects through dedicated electromedical devices. This pilot retrospective analytical observational study aims to evaluate the efficacy of a cycle of 5 sessions of needle-free infiltration (N-Fi) with the delivery of a gel based on hyaluronic acid, ozone and vitamin C in reducing pain, measured with the Numeric Pain Rating Scale (NPRS), and postural dysfunction, measured with the computerized calculation of the Postural Biometric Index (PBI). Data from 30 patients (mean age 56±13 years) affected by MPS were considered. At the end of the study, a significant reduction in the NPRS score (-41.9%) and PBI (-31.1%) values was observed. Therefore, our observations confirm that MPS patients treated with N-Fi show a significant improvement in pain and biomechanical-postural dysfunction associated with their pathology. Further in-depth studies on the topic are recommended to confirm the preliminary results of our research.
KEYWORDS: Rehabilitation, physical therapy, trigger point, myofascial pain syndrome, injection
